Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies
Authors
Keywords
TK1, Surface expression, Membrane TK1, Thymidine kinase 1, Lung cancer, Breast cancer, Colon cancer
Journal
Cancer Cell International
Volume 18, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-10
DOI
10.1186/s12935-018-0633-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt’s lymphoma and acute lymphoblastic leukemia
- (2017) Evita Weagel et al. OncoTargets and Therapy
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people
- (2016) Yu Wang et al. Cancer Biomarkers
- Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
- (2016) Andrea Sartore-Bianchi et al. LANCET ONCOLOGY
- Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways
- (2016) Gemma Leon et al. PHARMACOLOGY & THERAPEUTICS
- A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease
- (2016) J. Kiran Kumar et al. TUMOR BIOLOGY
- Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results
- (2015) Mumtahena Rahman et al. BIOINFORMATICS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
- (2015) Devon A. Lawson et al. NATURE
- The level of HER2 expression is a predictor of antibody-HER2 trafficking behavior in cancer cells
- (2014) Sripad Ram et al. mAbs
- Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
- (2014) Sara Häggblad Sahlberg et al. PLoS One
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies
- (2013) Diana P. English et al. Molecular Diagnosis & Therapy
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
- (2012) Hyesil Seol et al. MODERN PATHOLOGY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma
- (2012) Bao-Jin Wu et al. TUMOR BIOLOGY
- Thymidine Kinase 1 Upregulation Is an Early Event in Breast Tumor Formation
- (2012) Melissa M. Alegre et al. Journal of Oncology
- Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
- (2009) A. Magnifico et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation